Studies have suggested the implant had higher failure rates than traditional hip replacements and has failed in some patients only a few years after implant due to metallic debris caused by an improperly implanted hip, according to the report.
Some physicians are criticizing DePuy for not stopping sales of the device earlier as evidence of the failing implants has been available “for some time,” according to the report.
Read the New York Times´ report on the DePuy ASR hip implant.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
